Paralysis Global Clinical Trials Review, H2, 2011

GlobalData, November 2011, Pages: 77

Paralysis Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H2, 2011" provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Paralysis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Paralysis Clinical Trials, Trial Designs, Trial Designs, Subjects Recruited, Unaccomplished Trials of Paralysis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Paralysis
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Paralysis
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Paralysis Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Clinical Trial Overview of Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
MacroGenics, Inc.
Clinical Trial Overview of MacroGenics, Inc.
Otto Bock HealthCare GmbH
Clinical Trial Overview of Otto Bock HealthCare GmbH
Dynasplint Systems, Inc.
Clinical Trial Overview of Dynasplint Systems, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
U.S. Department of Veterans Affairs
Clinical Trial Overview of U.S. Department of Veterans Affairs
Case Western Reserve University
Clinical Trial Overview of Case Western Reserve University
National Institute of Neurological Disorders and Stroke
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
University of Florida
Clinical Trial Overview of University of Florida
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
Rouen University Hospital
Clinical Trial Overview of Rouen University Hospital
Columbia University
Clinical Trial Overview of Columbia University
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Universita degli Studi di Modena e Reggio Emilia
Clinical Trial Overview of Universita degli Studi di Modena e Reggio Emilia
Nagasaki University
Clinical Trial Overview of Nagasaki University
Federal University of Sao Paulo
Clinical Trial Overview of Federal University of Sao Paulo
Xijing Hospital
Clinical Trial Overview of Xijing Hospital
University of Alberta
Clinical Trial Overview of University of Alberta
Hillel Yaffe Medical Center
Clinical Trial Overview of Hillel Yaffe Medical Center
University Hospital, Toulouse
Clinical Trial Overview of University Hospital, Toulouse
Centre Hospitalier Universitaire de Saint Etienne
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
Shaare Zedek Medical Center
Clinical Trial Overview of Shaare Zedek Medical Center
Imperial College London
Clinical Trial Overview of Imperial College London
Rigshospitalet
Clinical Trial Overview of Rigshospitalet
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Paralysis Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2011-
Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Paralysis Therapeutics Clinical Trials, North America, Top Countries, 2011-
Paralysis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries, 2011-
Paralysis Therapeutics Clinical Trials, BRIC Countries, 2011-
Paralysis Therapeutics Clinical Trials, G7 Countries, 2011-
Paralysis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Paralysis Therapeutics Clinical Trials, E7 Countries, 2011-
Paralysis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Paralysis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Paralysis Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Paralysis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hugo W. Moser Research Institute at Kennedy Krieger, Inc., 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by MacroGenics, Inc., 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otto Bock HealthCare GmbH, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dynasplint Systems, Inc., 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi di Modena e Reggio Emilia, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki University, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillel Yaffe Medical Center, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2011-
Paralysis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2011-

List of Figures
Paralysis Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Paralysis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011-
Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Paralysis Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011-
Paralysis Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Paralysis Therapeutics Clinical Trials, G7 Countries (%), 2011-
Paralysis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Paralysis Therapeutics Clinical Trials, E7 Countries (%), 2011-
Paralysis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Paralysis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Paralysis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Paralysis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
GlobalData Methodology

Customers who bought this item also bought

• Cholangitis Global Clinical Trials Review, H1, 2013
• Strabismus Global Clinical Trials Review, H1, 2013
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Hemostasis Global Clinical Trials Review, H1, 2013
• Ulcers Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Alopecia Global Clinical Trials Review, H1, 2013
• Anal Fissure Global Clinical Trials Review, H1, 2013